🇺🇸 Dipyridamole 200 mg in United States

10 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Alanine Aminotransferase Increased — 1 report (10%)
  2. Antinuclear Antibody Positive — 1 report (10%)
  3. Ascites — 1 report (10%)
  4. Aspartate Aminotransferase Increased — 1 report (10%)
  5. Blood Alkaline Phosphatase Increased — 1 report (10%)
  6. Blood Bilirubin Increased — 1 report (10%)
  7. Confusional State — 1 report (10%)
  8. Dementia — 1 report (10%)
  9. Drug Interaction — 1 report (10%)
  10. Fall — 1 report (10%)

Source database →

Dipyridamole 200 mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Dipyridamole 200 mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Dipyridamole 200 mg in United States?

Vastra Gotaland Region is the originator. The local marketing authorisation holder may differ — check the official source linked above.